Medicine administration kit, percutaneous, medicated, single-use
Access comprehensive regulatory information for Medicine administration kit, percutaneous, medicated, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Sanofi-Aventis Australia Pty Ltd, manufactured by Sanofi Pasteur Inc in United States of America. The device registration started on March 07, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Fluquadri (AUST R 213963) is indicated for active immunisation of influenza disease and is available in 0.5mL injection pre-filled needle-free syringe. Seperate needle (either 5 or 10) will be provided in each pack of Fluquadri syringe for administraiton.